Patient and caregiver perspective on pediatric eosinophilic esophagitis and newly developed symptom questionnaires

ABSTRACT

Objective: Eosinophilic esophagitis (EE), a rare chronic inflammatory condition of the esophagus, is predominantly observed in children and is primarily manifested with feeding difficulties. To our knowledge, no self- or caregiver-reported questionnaires are available to assess pediatric EE symptoms and their impact as reported directly by children or their parents/caregivers. The objectives of this study were to characterize the symptoms and impact of EE among children as reported by patients and parents/caregivers and to assess the content validity of two newly developed pediatric eosinophilic esophagitis symptom questionnaires, one parent/caregiver-reported questionnaire for ages 2–7 years and one child-reported questionnaire for ages 8–17 years. The questionnaires were developed based on a review of the literature and clinical expert consultation.

Research design and methods: This cross-sectional study involving one-on-one interviews with patients and caregivers was conducted at an American Partnership for Eosinophilic Disorders conference. Parents of patients aged 2–7 years (n = 12) and patients aged 8–17 years (n = 16) were first asked about symptoms and their impact on everyday life, using open-ended questions. Participants then completed the appropriate symptom questionnaire and were asked to provide feedback on the relevance, comprehensiveness, and clarity of each item and other questionnaire issues (time to complete, length, format, etc.). All reported symptoms were enumerated, and the feedback on the symptom questionnaires was analyzed qualitatively.

Results: The majority of study participants were white (82%) and male (86%). The most frequently reported symptoms of 2–7-year olds were vomiting (92%), “reflux” (50%), dysphagia (25%), abdominal pain (25%), and trouble sleeping (25%). The 8–17-year group reported abdominal pain (56%), vomiting (31%), throat pain (25%), diarrhea (25%), and food getting stuck (25%). Symptoms and treatment were reported to have a major impact on daily life, particularly on school, after-school activities and social events, feeling frustrated regarding symptoms and treatment, and feeling “different”. Overall, participants thought that the questionnaires were clear, relevant, and appropriate for symptom assessment.

Limitation: This study was based on a small and convenient sample of participants attending an EE conference and hence may not be representative of the general EE patient population.

Conclusions: EE is associated with a range of symptoms that vary in terms of the type, frequency and severity across and within patients. The results provide adequate support for the content validity of the self- and caregiver-reported versions of the symptom-specific questionnaires. Minor modifications were made based on the feedback obtained. A psychometric evaluation of the revised questionnaires is needed next to assess the construct validity, reliability, and responsiveness of the measures.

Key words: :

• Pediatric eosinophilic esophagitis
• Questionnaire validation
• Symptoms

Acknowledgments

Declaration of interest: This study was funded by GlaxoSmithKline. M. A., C. J., O. D. and L. K. are employees of GlaxoSmithKline. The authors thank the members of American Partnership for Eosinophilic Disorders for their participation and/or assistance with conducting this research study, especially Beth Mays. We sincerely thank the children and their families who participated in the study for their contributions to this research.

Notes

* Data from this manuscript were presented at the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Annual Meeting, Orlando, FL, USA, 19–22 October, 2006